AC
RMD icon

Avestar Capital’s ResMed RMD Stock Holding History

Avestar Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,224
Closed -$335K – 512
2025
Q3 		$335K Buy
1,224
+399
+48% +$109K 0.02% 395
2025
Q2 		$213K Sell
825
-85
-9% -$20.3K 0.01% 455
2025
Q1 		$204K Sell
910
-279
-23% -$65.1K 0.02% 455
2024
Q4 		$272K Buy
1,189
+84
+8% +$20.2K 0.02% 405
2024
Q3 		$270K Buy
+1,105
New +$247K 0.03% 372
2019
Q3 		– Sell
-3
Closed – – 692
2019
Q2 		$0 Hold
3
– – ﹤0.01% 959
2019
Q1 		$0 Hold
3
– – ﹤0.01% 963
2018
Q4 		$0 Hold
3
– – ﹤0.01% 976
2018
Q3 		$0 Buy
+3
New +$329 ﹤0.01% 978

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Avestar Capital's RMD Position: Q4 2025 in Review

Avestar Capital sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,224 shares — an estimated $335K sold.

Avestar Capital first reported a position in RMD in Q3 2018 and held it in 9 quarters. The position peaked at $335K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Avestar Capital reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Avestar Capital sold 1,224 ResMed shares in Q4 2025, an estimated $335K.
  • Avestar Capital first reported a position in ResMed in Q3 2018 and held it in 9 quarters.
  • Avestar Capital's ResMed position peaked at $335K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Avestar Capital's 13F filing for Q4 2025, filed 10 Feb 2026.